Imperial College London Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes

Protac-mediated phospholamban ablation - A Chemical Biology approach to the treatment of heart failure

   College of Medicine, Veterinary and Life Sciences

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Dr Will Fuller, Dr David France  No more applications being accepted  Funded PhD Project (UK Students Only)

Glasgow United Kingdom Cell Biology Synthetic Chemistry

About the Project


Dr Will Fuller

Dr David France

Project summary:

Heart failure is one of the world’s biggest killers. In this multidisciplinary PhD project, you will work across two labs to bridge the divide between cardiovascular science and chemistry. We have identified a new strategy that could potentially be used to treat heart failure that relies on targeted protein degradation, an emerging strategy in medicinal chemistry. In this project, you will make a new set of small molecules called proteolysis targeting chimeras (PROTACs) and test them for efficacy against phospholamban, a key regulator of cardiac function. Knowledge of both cell biology and synthetic chemistry is essential, with experience in both a further positive.

Funding Notes

The studentship provides funding for tuition fees, a stipend and laboratory expenses for Home (UK) applicants only.
The MVLS/EPSRC grant provides tuition fees and stipend of at least £15,285 (UKRI rate 2020/21).
Please view application information here:
Once you have all the required application documentation, please apply here:
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.